BioTime Subsidiary ES Cell International and GE Healthcare Cross-License patents in the Field of Cell Assays for Drug Testing
Article Includes Bench Tips for Optimizing 3D Cell Culture with Customizable Hydrogels
BioTime Division ESI BIO Launches New Responsive Design Website to the Scientific Community
BioTime Organizes New ESI BIO Division to Develop, Manufacture and Market the Company’s Cell-Based Research Products - Appoints Jeffrey Janus as CEO of ES Cell International Pte Ltd.
BioTime CEO Dr. Michael West to Give Keynote Address at the MSC 2013 Adult Stem Cell Therapy & Regenerative Medicine Conference
Acquisition to Accelerate Development of Research and Therapeutic Products